Literature DB >> 1319499

Antioxidant-dependent amelioration of brain injury: role of CuZn-superoxide dismutase.

P H Chan1.   

Abstract

Copper-zinc-superoxide dismutase (CuZn-SOD), a cytosolic antioxidant enzyme that is specific for scavenging superoxide radicals, is involved in neuroprotective mechanisms in brain injury following trauma and cerebral ischemia. Liposome-entrapped CuZn-SOD exhibit beneficial effects in vivo on cold-induced vasogenic edema and on blood-brain barrier disruption. The increased levels of edema and infarction following a focal cerebral ischemia also are decreased by the pretreatment of liposome-entrapped CuZn-SOD. The protective role of SOD on brain injury was further extended and confirmed in studies using transgenic mice overexpressing human CuZn-SOD. Our studies so far suggest that increased cerebral levels of SOD, either by means of external pharmacological application or by genetic manipulations, ameliorate brain edema and infarction induced by trauma and focal cerebral ischemia.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1319499

Source DB:  PubMed          Journal:  J Neurotrauma        ISSN: 0897-7151            Impact factor:   5.269


  8 in total

1.  Therapeutic effect of liposomal superoxide dismutase in an animal model of retinopathy of prematurity.

Authors:  M R Niesman; K A Johnson; J S Penn
Journal:  Neurochem Res       Date:  1997-05       Impact factor: 3.996

2.  Inhibitory effects of prior low-dose X-irradiation on cold-induced brain injury in mouse.

Authors:  Masaaki Yoshimoto; Takahiro Kataoka; Teruaki Toyota; Takehito Taguchi; Kiyonori Yamaoka
Journal:  Inflammation       Date:  2012-02       Impact factor: 4.092

3.  Relations between the selenium status and the low T3 syndrome after major trauma.

Authors:  M M Berger; T Lemarchand-Béraud; C Cavadini; R Chioléro
Journal:  Intensive Care Med       Date:  1996-06       Impact factor: 17.440

4.  Effect of tirilazad mesylate given after permanent middle cerebral artery occlusion in rat.

Authors:  H O Hellström; A Wanhainen; J Valtysson; L Persson; L Hillered
Journal:  Acta Neurochir (Wien)       Date:  1994       Impact factor: 2.216

5.  Prophylactic Subacute Administration of Zinc Increases CCL2, CCR2, FGF2, and IGF-1 Expression and Prevents the Long-Term Memory Loss in a Rat Model of Cerebral Hypoxia-Ischemia.

Authors:  Victor Manuel Blanco-Alvarez; Guadalupe Soto-Rodriguez; Juan Antonio Gonzalez-Barrios; Daniel Martinez-Fong; Eduardo Brambila; Maricela Torres-Soto; Ana Karina Aguilar-Peralta; Alejandro Gonzalez-Vazquez; Constantino Tomás-Sanchez; I Daniel Limón; Jose R Eguibar; Araceli Ugarte; Jeanett Hernandez-Castillo; Bertha Alicia Leon-Chavez
Journal:  Neural Plast       Date:  2015-08-18       Impact factor: 3.599

Review 6.  Getting into the brain: liposome-based strategies for effective drug delivery across the blood-brain barrier.

Authors:  Débora B Vieira; Lionel F Gamarra
Journal:  Int J Nanomedicine       Date:  2016-10-18

Review 7.  Therapeutic uses of antioxidant liposomes.

Authors:  William L Stone; Shyamali Mukherjee; Milton Smith; Salil K Das
Journal:  Methods Mol Biol       Date:  2002

Review 8.  Therapeutic uses of antioxidant liposomes.

Authors:  William L Stone; Milton Smith
Journal:  Mol Biotechnol       Date:  2004-07       Impact factor: 2.695

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.